Vitamin D—Cellular Ca2+ link to obesity and diabetes

Journal of Steroid Biochemistry and Molecular Biology

Volumn 164, Issue , 2016, Pages 326-330

  Sergeev, Igor N ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

1,25 Dihydroxyvitamin D3; Apoptosis; Intracellular Ca2+; Obesity; Type 2 diabetes; Vitamin D status

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; CALCITRIOL; COLECALCIFEROL; GLUCOSE; INSULIN; PARATHYROID HORMONE; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; CALCITRIOL RECEPTOR; CALCIUM; VDR PROTEIN, HUMAN; VITAMIN D;

ADIPOCYTE; APOPTOSIS; CALCIUM SIGNALING; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPID DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; REVIEW; VITAMIN INTAKE; ANALOGS AND DERIVATIVES; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY;

ADIPOCYTES; ANIMALS; APOPTOSIS; CALCITRIOL; CALCIUM; CALCIUM SIGNALING; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; OBESITY; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 84947968359     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.11.008     Document Type: Review

References (60)

1. [1] Sergeev, I.N., Rhoten, W.B., Spirichev, V.B., Vitamin D and intracellular calcium. Subcell. Biochem. 30 (1998), 271–297.
2. [2] Norman, A.W., Nemere, I., Zhou, L.X., Bishop, J.E., Lowe, K.E., Maiyar, A.C., Collins, E.D., Taoka, T., Sergeev, I., Farach-Carson, M.C., 1,25(OH) 2-Vitamin D3, a steroid hormone that produces biological effects via genomic and nongenomic pathways. J. Steroid Biochem. Mol. Biol. 41 (1992), 231–240.
3. [3] Christakos, S., Hewison, M., Gardner, D.G., Wagner, C.L., Sergeev, I.N., Rutten, E., Pittas, A.G., Boland, R., Ferrucci, L., Bilke, D.D., Vitamin D: beyond bone. Ann. N. Y. Acad. Sci. 1287 (2013), 45–58.
4. 3: a link between metabolic disorders and breast cancer. Horm. Mol. Biol. Clin. Invest. 14 (2013), 99–106.
5. [5] Sergeev, I.N., Vitamin D-mediated apoptosis in cancer and obesity. Horm. Mol. Biol. Clin. Invest. 20 (2014), 43–49.
6. [6] Norman, A.W., Bouillon, R., Vitamin D nutritional policy needs a vision for the future. Exp. Biol. Med. 235 (2010), 1034–1045.
7. 2+ signaling in breast cancer. Anticancer Res. 32 (2012), 299–302.
8. [8] Sergeev, I.N., Calcium signaling in cancer and vitamin D. J. Steroid Biochem. Mol. Biol 97 (2005), 145–151.
9. [9] Sergeev, I.N., Calcium as a mediator of 1,25-dihydroxyvitamin D3-induced apoptosis. J. Steroid Biochem. Mol. Biol. 89–90 (2004), 419–425.
10. [10] Berridge, M.J., Bootman, M.D., Lipp, P., Calcium: a life and death signal. Nature 395 (1988), 645–648.
11. [11] Orrenius, S., Zhivotovsky, B., Nicotera, P., Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4 (2003), 552–565.
12. [12] Sergeev, I.N., Rhoten, W.B., 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic β-cell line. Endocrinology 136 (1995), 2852–2861.
13. [13] Song, Q., Sergeev, I.N., Calcium and vitamin D in obesity. Nutr. Res. Rev. 25 (2012), 130–141.
14. [14] Vucenik, I., Stains, J.P., Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann. N. Y. Acad. Sci. 1271 (2012), 37–43.
15. [15] Mathiasen, I.S., Sergeev, I.N., Bastholm, L., Elling, F., Norman, A.W., Jaattela, M., Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J. Biol. Chem 277 (2002), 30738–30745.
16. [16] Sergeev, I.N., Rhoten, W.B., Regulation of intracellular calcium in breast cancer cells. Endocrine 9 (1998), 321–327.
17. [17] Li, M., Chen, P., Li, J., Chu, R., Xie, D., Wang, H., The impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 99 (2014), 2327–2336.
18. 3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 99 (2014), 3551–3560.
19. [19] Sergeev, I.N., 1,25-Dihydroxyvitamin D3 induces Ca2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem. Biophys. Res. Commun 384 (2009), 18–21.
20. 2+ in butyrate-treated rat insulinoma cells. Endocrine 2 (1994), 989–995.
21. [21] Satin, L.S., Butler, P.C., Ha, J., Sherman, A.S., Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes. Mol. Aspects Med 42 (2015), 61–77.
22. [22] Sergeev, I.N., Vitamin D/calcium-mediated apoptosis in cancer cells and adipocytes. FASEB J., 24(917), 2010, 16.
23. 2+-dependent calpain and caspases: novel molecular targets for obesity-related breast cancer drug discovery. FASEB J., 28, 2014, 261.5.
24. [24] Nemere, I., Hintze, K., Novel hormone receptors. J. Cell Biochem. 103 (2008), 401–407.
25. 2+ signaling. FASEB J., 26, 2012, 386.2.
26. 2+-mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells. Biochem. Biophys. Res. Commun. 321 (2004), 462–467.
27. [27] Sergeev, I.N., Norman, A.W., 1,25-Dihydroxyvitamin D3 and calcium signaling. Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects, 2000, Univ. California, Riverside, 715–718.
28. 2+ and apoptosis in breast cancer cells. Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, 1997, Univ. California, Riverside, 473–474.
29. [29] Sergeev, I.N., Colby, J., Norman, A.W., 1,25-Dihydroxyvitamin D3 triggers calcium-mediated apoptosis in breast cancer cells. Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects, 2000, Univ. California, Riverside, 399–402.
30. [30] Carafoli, E., Santella, L., Branca, D., Brini, M., Generation, control, and processing of cellular calcium signals. Crit. Rev. Biochem. Mol. Biol. 36 (2001), 107–260.
31. [31] McConkey, D.L., Orrenius, S., The role of calcium in regulation of apoptosis. Biochem. Biophys. Res. Commun. 239 (1997), 357–366.
32. [32] Carafoli, E., Molinari, M., Calpain: a protease in search of a function?. Biochem. Biophys. Res. Commun. 247 (1998), 193–203.
33. 2+-mediated apoptosis in breast cancer cells. Life Sci. 80 (2006), 245–253.
34. [34] Sergeev, I.N., Ho, C.-T., Lee, S., Colby, J., Dushenkov, S., Apoptosis-inducing activity of hydroxylated polymethoxyflavones and polymethoxyflavones from orange peel in human breast cancer cells. Mol. Nutr. Food Res. 51 (2007), 1478–1484.
35. 2+-dependent apoptotic targets in adipocytes. J Agric. Food Chem. 57 (2009), 5771–5776.
36. [36] Sergeev, I.N., Rhoten, W.B., Carney, M.D., Calbindins decreased after space flight. Endocrine 5 (1996), 335–340 Cover illustration.
37. [37] Sergeev, I.N., Norman, A.W., Calcium as a mediator of apoptosis in bovine oocytes and preimplantation embryos. Endocrine 22 (2003), 169–176.
38. 3 in rat osteosarcoma cells: structure-function studies using ligand analogs. Endocrinology 129 (1991), 1876–1884.
39. [39] Sergeev, I.N., Song, Q., High vitamin D and calcium intakes reduce diet-induced obesity in mice by increasing adipose tissue apoptosis. Mol. Nutr. Food Res. 58 (2014), 1342–1348.
40. [40] Song, Q., Sergeev, I.N., High vitamin D and calcium intakes increase bone mineral (Ca and P) content in high-fat diet-induced obese mice. Nutr. Res. 35 (2015), 146–154.
41. [41] Henquin, J.C., Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49 (2000), 1751–1760.
42. 2+ in pancreatic islets correspond to pulsatile insulin release. Am. J. Physiol. 268:2 Pt. 1 (1995), E282–287.
43. 3 and two analogs. Cancer Res. 53 (1993), 3935–3942.
44. [44] Spirichev, V.B., Sergeev IN. Vitamin D: experimental research and its practical application. World Rev. Nutr. Diet. 56 (1988), 173–216.
45. [45] Bouillon, R., Lieben, L., Mathieu, C., Verstuyf, A., Carmeliet, G., Vitamin, D., action: lessons from VDR and Cyp27b1 null mice. Pediatr. Endocrinol. Rev.(Suppl. 2), 2013, 354–366.
46. [46] Demay, M.B., Physiological insights from the vitamin D receptor knockout mouse. Calcif. Tissue Int. 92 (2013), 99–105.
47. [47] Kato, S., Takeyama, K., Kitanaka, S., Murayama, A., Sekine, K., Yoshizawa, T., In vivo function of VDR in gene expression-VDR knock-out mice. J. Steroid Biochem. Mol. Biol. 69 (1999), 247–251.
48. [48] Narvaez, C.J., Matthews, D., Broun, E., Chan, M., Welsh, J.E., Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 150 (2009), 651–661.
49. [49] Mutt, S.J., Hyppönen, E., Saarnio, J., Järvelin, M.R., Herzig, K.H., Vitamin D and adipose tissue—more than storage. Front. Physiol., 5, 2014, 228.
50. [50] Bikle, D.D., Oda, Y., Tu, C.L., Jiang, Y., Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer. J. Steroid Biochem. Mol. Biol. 148 (2015), 47–51.
51. [51] Ogunkolade, B.W., Boucher, B.J., Prahl, J.M., Bustin, S.A., Burrin, J.M., Noonan, K., North, B.V., Mannan, N., McDermott, M.F., DeLuca, H.F., Hitman, G.A., Vitamin, D., receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51 (2002), 2294–2300.
52. [52] Ramagopalan, S.V., Heger, A., Berlanga, A.J., Maugeri, N.J., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 20 (2010), 1352–1360.
53. [53] Mitri, J., Pittas, A.G., Vitamin D and diabetes. Endocrinol. Metab. Clin. North Am. 43 (2014), 205–232.
54. [54] Mitri, J., Muraru, M.D., Pittas, A.G., Vitamin, D., and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 65 (2011), 1005–1015.
55. 3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 99 (2014), 3551–3560.
56. [56] Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., Esmaillzadeh, A., Effects of calcium–vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 57 (2014), 2038–2047.
57. [57] Oosterwerff, M.M., Eekhoff, E.M., Van Schoor, N.M., Boeke, A.J., Nanayakkara, P., Meijnen, R., Knol, D.L., Kramer, M.H., Lips, P., Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D-deficient non-western immigrants in the Netherlands: a randomized placebo-controlled trial. Am. J. Clin. Nutr. 100 (2014), 152–160.
58. [58] Krul-Poel, Y.H., Westra, S., ten Boekel, E., ter Wee, M.M., van Schoor, N.M., van Wijland, H., Stam, F., Lips, P.T., Simsek, S., Effect of Vitamin D supplementation on glycemic control in patients with type 2 diabetes (SUNNY Trial): a randomized placebo-controlled trial. Diabetes Care 38 (2015), 1420–1426.
59. [59] Chandler, P.D., Wang, L., Zhang, X., Sesso, H.D., Moorthy, M.V., Obi O2 Lewis, J., Prince, R.L., Danik, J.S., Manson, J.E., LeBoff, M.S., Song, Y., Effect of vitamin D supplementation alone or with calcium on adiposity measures: a systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 73 (2015), 577–593.
60. [60] Ceglia, L., Nelson, J., Ware, J., Alysandratos, K.D., Bray, G.A., Garganta, C., Nathan, D.M., Hu, F.B., Dawson-Hughes, B., Pittas, A.G., Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program. Eur. J. Nutr.(November), 2015, 10.1007/s00394-015-1066-z (epub ahead of print).